GLP1R and type 2 diabetes mellitus: There is a large need for effective pharmacotherapies for AUD that can be tailored to individual risk factors and/or also provide a biologically oriented treatment integrated with individualized psychotherapies.38 Notably, GLP-1 analogs are already approved and clinically used for the treatment of type 2 diabetes.